Form 4 for INFQ Infleqtion, Inc.
Accepted 2026-06-01 21:45:10 ET · period of report 2026-05-28 · accession 0001116268-26-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2026-06-01 21:45 | 2026-05-28 | INFQ | JOHNSON KRISTINA M | Dir | S - Sale+OE | $18.00 | -20.0K | 13.1K | -60% | -$360.0K |
| D | 2026-06-01 21:45 | 2026-05-28 | INFQ | JOHNSON KRISTINA M | Dir | M - OptEx | $0.9 | +30.0K | 30.0K | New | +$27.0K |
| D | 2026-06-01 21:45 | 2026-05-28 | INFQ | JOHNSON KRISTINA M | Dir | S - Sale+OE | $16.45 | -30.0K | 0 | -100% | -$493.5K |
| D | 2026-06-01 21:45 | 2026-05-28 | INFQ | JOHNSON KRISTINA M | Dir | M - OptEx | $0.00 | -30.0K | 343.5K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-28 | S | D | 20,000 | $18.00 | 13,120 | I See footnote | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.85 to $18.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. (F2) Held directly by Catalyzer Ventures, LP Fund I ("Catalyzer"). Dr. Johnson is a general partner of Catalyzer. Dr. Johnson disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein. |
| 2 | Common | Common Stock | 2026-05-28 | M | A | 30,000 | $0.9 | 30,000 | D | — | — | |
| 3 | Common | Common Stock | 2026-05-28 | S | D | 30,000 | $16.45 | 0 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.45 to $16.47 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Derivative | Stock Option (Right to Buy) | 2026-05-28 | M | D | 30,000 | $0.00 | 343,458 | D | $0.9 · — to 2034-06-05 | 30,000 Common Stock | (F4) The shares vest on a monthly basis beginning on June 1, 2024 with respect to 1/36 of the total number of shares until such time as the option is 100% vested, subject to the continuous service of the Reporting Person as of each such date. |